Abstract
In this issue of Blood, Shanafelt and colleagues demonstrate that T-cell immune synapse function can be increased in chronic lymphocytic leukemia (CLL), both by reducing tumor burden with immunochemotherapy and by lenalidomide.
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Consolidation Chemotherapy*
-
Humans
-
Immunological Synapses / physiology*
-
Immunotherapy*
-
Lenalidomide
-
Leukemia, Lymphocytic, Chronic, B-Cell / therapy*
-
T-Lymphocytes / immunology*
-
Thalidomide / administration & dosage
-
Thalidomide / analogs & derivatives*